Jason B White
Overview
Explore the profile of Jason B White including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rinkenbaugh A, Qi Y, Cai S, Shao J, Hancock F, Jeter-Jones S, et al.
bioRxiv
. 2024 Dec;
PMID: 39651299
Triple negative breast cancer (TNBC) that fails to respond to neoadjuvant chemotherapy (NACT) can be lethal. Developing effective strategies to eradicate chemoresistant disease requires experimental models that recapitulate the heterogeneity...
2.
Yam C, Patel M, Hill H, Sun R, Bassett Jr R, Kong E, et al.
Cancer Res Commun
. 2024 Oct;
4(10):2823-2834.
PMID: 39356138
Purpose: Epidermal growth factor receptor (EGFR) pathway activation causes chemotherapy resistance, and inhibition of the EGFR pathway sensitizes triple-negative breast cancer (TNBC) cells to chemotherapy in preclinical models. Given the...
3.
Chen J, Addanki S, Roy D, Bassett R, Kalashnikova E, Spickard E, et al.
BMC Cancer
. 2024 Aug;
24(1):1016.
PMID: 39148033
Background: Triple negative breast cancer (TNBC) is an aggressive subtype with poor prognosis. We aimed to determine whether circulating tumor DNA (ctDNA) and circulating tumor cell (CTC) could predict response...
4.
Powell R, Rinkenbaugh A, Guo L, Cai S, Shao J, Zhou X, et al.
NPJ Breast Cancer
. 2024 May;
10(1):37.
PMID: 38802426
Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancer cases in the United States. Systemic neoadjuvant chemotherapy (NACT), with or without immunotherapy, is the current standard of care...
5.
Basho R, Zhao L, White J, Huo L, Bassett R, Mittendorf E, et al.
JCO Precis Oncol
. 2024 Mar;
8:e2300124.
PMID: 38484209
Purpose: The PI3K pathway is frequently altered in triple-negative breast cancer (TNBC). Limited cell line and human data suggest that TNBC tumors characterized as mesenchymal (M) and luminal androgen receptor...
6.
Musall B, Rauch D, Mohamed R, Panthi B, Boge M, Candelaria R, et al.
J Magn Reson Imaging
. 2024 Jan;
60(4):1367-1376.
PMID: 38294179
Background: Assessment of treatment response in triple-negative breast cancer (TNBC) may guide individualized care for improved patient outcomes. Diffusion tensor imaging (DTI) measures tissue anisotropy and could be useful for...
7.
Zhou Z, Adrada B, Candelaria R, Elshafeey N, Boge M, Mohamed R, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2023 Dec;
2023:1-4.
PMID: 38083160
We trained and validated a deep learning model that can predict the treatment response to neoadjuvant systemic therapy (NAST) for patients with triple negative breast cancer (TNBC). Dynamic contrast enhanced...
8.
Chen H, Ding Q, Khazai L, Zhao L, Damodaran S, Litton J, et al.
Ther Adv Med Oncol
. 2023 Aug;
15:17588359231189422.
PMID: 37547448
Background: Recent advances have been made in targeting the phosphoinositide 3-kinase pathway in breast cancer. Phosphatase and tensin homolog (PTEN) is a key component of that pathway. Objective: To understand...
9.
Hwang K, Elshafeey N, Kotrotsou A, Chen H, Son J, Boge M, et al.
Radiol Imaging Cancer
. 2023 Jul;
5(4):e230009.
PMID: 37505106
Purpose To determine if a radiomics model based on quantitative maps acquired with synthetic MRI (SyMRI) is useful for predicting neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)....
10.
Ishida A, Bazyler C, Suarez D, Slaton J, White J, Stone M
J Sports Sci
. 2023 May;
41(3):209-216.
PMID: 37125864
The purposes of this study were to investigate the acute effects of resistance training protocol on kinetic changes in squat jump (SJ), shortened isometric mid-thigh pull (IMTP), and isometric squat...